.png){kind=icon}
.png){kind=icon}
Return
Emergence of chloroquine-sensitive Plasmodium falciparum and rising resistance to first-line artemisinin partner drugs in Malawi
.png){kind=icon}
OA
AI
E
H
W
J
J
F
F
M
F
J
T
S
S
W
W
E
W
J
DOI：10.1080/22221751.2025.2572679.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The emergence and spread ofPlasmodium falciparumresistance to malaria drugs pose a major threat to malaria control efforts. This study assessed the prevalence of molecular markers associated with resistance to key antimalarials inP. falciparumclinical isolates from Mzuzu and Lilongwe in Malawi. These two regions have high human mobility and are strategically located near the border with Zambia and Tanzania, respectively. A total of 1582 blood samples were collected from individuals who visited hospitals for diagnosis between December 2020 and June 2021.P. falciparuminfections were confirmed using nested and quantitative PCR, and drug resistance marker genes (pfmdr1,pfcrt, pfk13,pfatp6,pfdhfr, andpfdhps) were sequenced by Sanger sequencing. No resistance-associated mutations were detected inpfk13andpfcrtgenes, supporting continued susceptibility to artemisinin derivatives and chloroquine (CQ). However, thepfmdr1-NFD haplotype, linked to reduced lumefantrine (LUM) susceptibility, was present in 159/371 (42.9%) isolates. Notably, the quadruplepfdhfr-pfdhpsmutant haplotype (AIRNVI-SGEAA), associated with high-level sulfadoxine-pyrimethamine (SP) resistance, was found in 287/328 (87.5%) of isolates. These findings highlight the ongoing risk of declining efficacy of LUM partner drugs in artemisinin-based combination therapies (ACT) and reduced SP effectiveness for intermittent preventive treatment in pregnancy (IPTp). The absence ofpfcrtmutations, together with the presence of wild-type pfmdr1 alleles lacking CQ-related mutation, suggests the re-emergence of CQ-sensitive parasites. Continuous molecular surveillance, alongside clinical efficacy studies, is essential to inform treatment policies and prevent the spread of drug-resistant malaria in Malawi.
Keywords:
Antimalarials
Plasmodium falciparum
Malawi
drug resistance
molecular surveillance
chloroquine
artemether-lumefantrine
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
7.5
Papers:
2.4K
Citations:
1.1W
Organization
Cited Papers